Victor Gurewich

5.4k total citations · 1 hit paper
144 papers, 4.0k citations indexed

About

Victor Gurewich is a scholar working on Hematology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Victor Gurewich has authored 144 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hematology, 58 papers in Cancer Research and 48 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Victor Gurewich's work include Protease and Inhibitor Mechanisms (58 papers), Blood Coagulation and Thrombosis Mechanisms (51 papers) and Blood properties and coagulation (44 papers). Victor Gurewich is often cited by papers focused on Protease and Inhibitor Mechanisms (58 papers), Blood Coagulation and Thrombosis Mechanisms (51 papers) and Blood properties and coagulation (44 papers). Victor Gurewich collaborates with scholars based in United States, China and France. Victor Gurewich's co-authors include Ralph Pannell, Bogusław Lipiński, Hershel Jick, Susan S. Jick, Michael W. Myers, Duncan P. Thomas, Stefan Niewiarowski, Jian‐Ning Liu, S. Shaukat Husain and Stanford Wessler and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Victor Gurewich

137 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

1995 509 citations Victor Gurewich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Victor Gurewich United States	32	1.5k	1.0k	1.0k	864	862	144	4.0k
F Bachmann Switzerland	42	2.0k 1.3×	863 0.8×	1.6k 1.6×	1.5k 1.7×	1.2k 1.4×	116	5.6k
B. Wiman Sweden	31	1.8k 1.2×	1.1k 1.1×	1.8k 1.7×	509 0.6×	324 0.4×	68	3.8k
D C Stump United States	33	1.0k 0.7×	716 0.7×	701 0.7×	1.2k 1.4×	657 0.8×	67	3.1k
M Verstraete Belgium	32	1.4k 0.9×	1.1k 1.1×	730 0.7×	1.8k 2.1×	1.0k 1.2×	157	4.6k
Francisco España Spain	42	2.3k 1.5×	890 0.9×	1.1k 1.1×	819 0.9×	748 0.9×	177	5.2k
Norma Alkjærsig United States	37	1.8k 1.2×	1.6k 1.6×	1.3k 1.2×	569 0.7×	349 0.4×	85	4.9k
Frederick A. Ofosu Canada	40	2.8k 1.8×	619 0.6×	369 0.4×	1.4k 1.6×	1.7k 2.0×	162	5.2k
Ulla Hedner Sweden	56	6.6k 4.4×	1.2k 1.2×	361 0.4×	1.0k 1.2×	1.2k 1.4×	292	9.1k
Laszlo Bajzar Canada	27	2.5k 1.7×	707 0.7×	649 0.6×	817 0.9×	559 0.6×	38	3.5k
Joseph P. Miletich United States	37	4.7k 3.1×	782 0.8×	713 0.7×	1.8k 2.1×	2.0k 2.4×	59	7.2k

Countries citing papers authored by Victor Gurewich

Since Specialization

Citations

This map shows the geographic impact of Victor Gurewich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Gurewich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Gurewich more than expected).

Fields of papers citing papers by Victor Gurewich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Gurewich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Gurewich. The network helps show where Victor Gurewich may publish in the future.

Co-authorship network of co-authors of Victor Gurewich

This figure shows the co-authorship network connecting the top 25 collaborators of Victor Gurewich. A scholar is included among the top collaborators of Victor Gurewich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victor Gurewich. Victor Gurewich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gurewich, Victor, et al.. (2025). Reperfusion of ischemia in the heart or brain. Journal of Pharmacology and Experimental Therapeutics. 392(3). 103392–103392.

Gurewich, Victor. (2020). Fibrinolytic therapy with tPA failed because it was based on a flawed concept. 5(2). 131–135. 1 indexed citations

Gurewich, Victor. (2019). Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown. Cardiovascular Drugs and Therapy. 33(6). 749–753. 5 indexed citations

Gurewich, Victor. (2018). What Fibrinolytic Therapy can Learn from Natural Fibrinolysis: Both Activators are a Requirement. 3. 1–3. 1 indexed citations

Gurewich, Victor. (2016). Therapeutic Fibrinolysis. Journal of the American College of Cardiology. 68(19). 2099–2106. 19 indexed citations

Gurewich, Victor. (2015). Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement. Journal of Thrombosis and Thrombolysis. 40(4). 480–487. 6 indexed citations

Lacroix, Romaric, Florence Sabatier, Agnès Mialhe, et al.. (2007). Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood. 110(7). 2432–2439. 164 indexed citations

Wang, Ping, Jing Zhang, Ziyong Sun, et al.. (2000). Catalytic and fibrinolytic properties of recombinant urokinase plasminogen activator from E. coli, mammalian, and yeast cells. Thrombosis Research. 100(5). 461–467. 12 indexed citations

Sun, Ziyong, Yongping Jiang, Hui Wu, et al.. (1997). Identification of a Flexible Loop Region (297–313) of Urokinase-type Plasminogen Activator, Which Helps Determine Its Catalytic Activity. Journal of Biological Chemistry. 272(38). 23818–23823. 17 indexed citations

10.

Zarich, Stuart, Glen J. Kowalchuk, W. Douglas Weaver, et al.. (1995). Sequential combination thrombolytic therapy for acute myocardial infarction: results of the pro-urokinase and t-PA enhancement of thrombolysis (PATENT) trial. Journal of the American College of Cardiology. 26(2). 374–379. 35 indexed citations

11.

Gurewich, Victor. (1989). The sequential, complementary and synergistic activation of fibrin-bound plasminogen by tissue plasminogen activator and pro-urokinase. Fibrinolysis and Proteolysis. 3(2). 59–66. 26 indexed citations

12.

Gurewich, Victor. (1987). Experiences with pro-urokinase and potentiation of its fibrinolytic effect by urokinase and by tissue plasminogen activator. Journal of the American College of Cardiology. 10(5). 16B–21B. 26 indexed citations

13.

Gurewich, Victor & Ralph Pannell. (1987). Fibrin Binding and Zymogenic Properties of Single-Chain Urokinase (Pro-urokinase). Seminars in Thrombosis and Hemostasis. 13(2). 146–151. 9 indexed citations

14.

Gurewich, Victor. (1978). Hemostatic Effects of Uniform, Low-Dose Subcutaneous Heparin in Surgical Patients. Archives of Internal Medicine. 138(1). 41–41. 16 indexed citations

15.

Gurewich, Victor & Bogusław Lipiński. (1976). Semiquantitative Determination of Soluble Fibrin Monomer Complexes by Chromatography and Serial-dilution Protamine Sulfate Test. American Journal of Clinical Pathology. 65(3). 397–401. 14 indexed citations

16.

Lipiński, Bogusław, et al.. (1974). The effect of heparin and dipyridamole on the deposition of fibrin-like material in rabbits infused with soluble fibrin monomer or fibrinogen. Thrombosis Research. 5(3). 343–357. 5 indexed citations

17.

Gurewich, Victor, et al.. (1974). The Role of Fibrin Monomer and an in vivo Thrombin‐Induced Anticoagulant in Experimental Venous Thrombosis. Scandinavian Journal of Haematology. 12(3). 204–212. 8 indexed citations

18.

Nowak, Andrzej & Victor Gurewich. (1974). Thrombolysis with Streptokinase in Rabbits Dose Response, Fibrin-clot Specificity and Laboratory Evaluation of Fibrinolytic Effect. Thrombosis and Haemostasis. 31(2). 265–272. 7 indexed citations

19.

Roberts, V.C., Saher S. Sabri, M Pietroni, Victor Gurewich, & L T Cotton. (1971). Passive Flexion and Femoral Vein Flow: A Study Using a Motorized Foot Mover. BMJ. 3(5766). 78–81. 31 indexed citations

20.

Gurewich, Victor, et al.. (1970). Streptokinase in acute pulmonary embolism. Journal of Thoracic and Cardiovascular Surgery. 59(5). 655–661. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact